Abstract

Establishing treatment guidelines, improving capacity to monitor antimicrobial susceptibility, and adequate supply of quality medications are key strategies to slow the spread of resistant gonorrhoea. Advances in the public health and clinical management of N gonorrhoeae stem from basic research on the biology of the organism, the development of diagnostic capabilities, and the availability of more effective drugs. The “bench to practise” translation of this research is vital to building capacity.

This presentation will focus on the gonorrhoea resistance research and training opportunities to contribute to the prevention and control efforts.